New rapid test could simplify diabetes monitoring

NCT ID NCT05403853

Completed Diagnosis Sponsor: LumiraDx UK Limited Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new rapid blood test (LumiraDx HbA1c) to see how well it measures blood sugar control in people with diabetes. Researchers compared it to a standard lab method in 177 adults. The goal was to see if the quick test is accurate enough for routine diabetes monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If the test works well, it could provide faster, easier diabetes monitoring at the point of care.
What could go wrong: This is a small, completed device comparison study, not a treatment trial. The test may not be as accurate in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES

Contacts and locations

Locations

Intelligent Clinical

Glasgow, United Kingdom
NHS Lanarkshire

Glasgow, United Kingdom
Ninewells Hospital, Dundee

Dundee, United Kingdom
Victoria Hospital

Kirkcaldy, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.